Regeneron will provide the U.S. with 300,000 doses of its newly authorized Covid-19 antibody treatment by early January, the company’s CEO, Dr. Leonard Schleifer, said Monday.
The Food and Drug Admi… [read more]
Regeneron will provide the U.S. with 300,000 doses of its newly authorized Covid-19 antibody treatment by early January, the company’s CEO, Dr. Leonard Schleifer, said Monday.
The Food and Drug Admi… [read more]